Objective To assess the long-term safety of MF59-adjuvanted trivalent influenza vaccine
(aIIV3; Fluad™) in adults≥ 65 years of age. Methods Data from 36 primary vaccination and …

The most effective means of preventing seasonal influenza is through vaccination. In this
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …

Elderly people and subjects with underlying chronic diseases are at increased risk for
influenza and related complications. Conventional influenza vaccines provide only limited …

Background: Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …

Background. Influenza vaccine immunogenicity is suboptimal in older persons. Intradermal
(ID) vaccination may be a promising alternative to intramuscular (IM) vaccination. Methods …

BACKGROUND: The potential consequences of an avian influenza pandemic warrants the
development of safe, highly immunogenic pre-pandemic A/H5N1 vaccines with cross-clade …

Influenza infection is associated with many complications, which can lead to hospitalizations
and death. This is particularly true for the older adults who are not able to mount as good an …

The vaccine efficacy of standard-dose seasonal inactivated influenza vaccines (S-IIV) can
be improved by the use of vaccines with higher antigen content or adjuvants. We conducted …

Intradermal seasonal influenza vaccine delivered by a microneedle injection system
(Intanza®) contains inactivated split virion antigens from influenza type A (H1N1 and H3N2) …

Influenza directly or indirectly contributes to the four leading causes of global mortality, at
rates that are highest in older adults. As the proportion of older adults in the Korean …